The media has been quick to discuss research findings on vitamin D supplementation's potential role in combating osteoporosis, correcting deficiency in chronic kidney disease, improving heart health, and extending life, which raises the question of whether patients should be screened routinely for vitamin D deficiency.
Well-trained pharmacy technicians can free up pharmacists' time for osteoporosis management services by identifying patients who do not require pharmacist intervention.
Drugs commonly used to treat osteoporosis may benefit patients with diseases like breast cancer.
Current risk assessment strategies for reducing fractures related to osteoporosis among women fail to accurately predict who will experience major osteoporotic injuries.
Pharmacist-led drug use evaluation programs improve osteoporosis management in general practice.
In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.
Fall and injuries in the elderly may be attributed to many popular prescription medications.
Patients with prostate cancer may benefit from bone mineral density screenings prior to initiation of therapy, researchers concluded.
The results of a secondary analysis of the FLEX trial do not support regular bone density monitoring within the first few years of discontinuing alendronate therapy.
Supplementation with calcium and vitamin D led to significantly reduced risk of hip fracture when combined with postmenopausal hormone therapy, a recent study finds.
Pharmacists can help their patients determine the best way to meet their daily calcium requirements.
Compared with men whose maternal or paternal grandfather had not broken a hip, grandsons of grandfathers with hip fracture were found to be at a 3% to 5% increased risk of osteoporosis.
A diet low in meat and carbohydrates but with plenty of extra virgin olive oil appears to protect the bones of older men, according to the results of a study.
The generic marketplace remains dynamic and complicated, as patent expirations,interest in biosimilars, and international competition spur major changes.
Less than a quarter know that most fractures in epilepsy patients are unassociated with seizures, according to a recent study.
Postmenopausal women are more likely to start medication therapy following osteoporotic fractures if they receive counseling from a pharmacist, a study suggests.
Pharmacists can advise patients on medications and lifestyle changes to help prevent or treat osteoporosis.
A federal government task force report advised against taking daily vitamin D and calcium supplements to prevent fractures.
Studies suggest minimal improvements after 5 years of bisphosphonate use, and long-term use has been associated with serious, although rare, side effects.
